Related Experiment Video
Updated: Feb 21, 2026

Probing Myosin Ensemble Mechanics in Actin Filament Bundles Using Optical Tweezers
Published on: May 4, 2022
Cardiac actin changes in the actomyosin interface have different effects on myosin duty ratio
Haidun Liu1,1, Mary Henein1,1, Maria Anillo1,1
1Department of Molecular and Cellular Biology and the Centre for Cardiovascular Investigations, University of Guelph, Guelph, ON N1G 2W1, Canada.
Insights
Hypertrophic cardiomyopathy (HCM) linked actin variants do not alter myosin duty ratio, suggesting other factors contribute to this inherited heart disease. Further research is needed to understand HCM development.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Inherited Cardiovascular Diseases
Background:
- Hypertrophic cardiomyopathy (HCM) is an inherited cardiovascular disease characterized by left ventricular hypertrophy.
- Cardiac muscle contraction involves the actomyosin ATPase cycle, with myosin's duty ratio (r) being crucial for force generation.
- A prevailing hypothesis suggests HCM-associated mutations enhance cardiac sarcomere contraction, but evidence remains inconclusive.
Purpose of the Study:
- To investigate whether human α-cardiac actin (ACTC) variants linked to HCM alter myosin's duty ratio (r).
- To test the hypothesis that ACTC variants near the myosin binding site increase myosin binding to actin, thereby increasing force production.
Main Methods:
- Calculated myosin duty ratios (r) using human ACTC variant proteins.
- Assessed myosin ATPase activity and in-vitro motility assays to determine r.
- Utilized established biochemical and biophysical techniques for protein analysis.
Main Results:
- No consistent alterations in the duty ratio (r) were observed for the studied ACTC variants.
- Myosin's interaction with HCM-linked ACTC variants did not significantly change under experimental conditions.
- The findings do not support the hypothesis that increased myosin duty ratio is a primary mechanism in HCM caused by these ACTC variants.
Conclusions:
- The duty ratio of myosin is not consistently affected by HCM-linked ACTC variants near the myosin binding site.
- These findings suggest that other molecular or cellular factors, beyond altered myosin duty ratio, likely contribute to the pathogenesis of HCM in the presence of ACTC variants.
- Further investigation is warranted to elucidate the complete mechanisms underlying HCM development.
Abstract:
Hypertrophic cardiomyopathy (HCM) is an inherited cardiovascular disease (CD) that commonly causes an increased size of cardiomyocytes in the left ventricle. The proteins myosin and actin interact in the myocardium to produce contraction through the actomyosin ATPase cycle. The duty ratio (r) of myosin is the proportion of the actomyosin ATPase cycle that myosin is bound to actin and does work. A common hypothesis is that HCM mutations increase contraction in cardiac sarcomeres; however, the available data are not clear on this connection. Based on previous work with human α-cardiac actin (ACTC), we hypothesize that HCM-linked ACTC variants with alterations near the myosin binding site have an increased r, producing more force. Myosin duty ratios using human ACTC variant proteins were calculated with myosin ATPase activity and in-vitro motility data. We found no consistent changes in the duty ratio of the ACTC variants, suggesting that other factors are involved in the development of HCM when ACTC variants are present.
More Related Videos
08:29Assessment of Myofilament Ca2+ Sensitivity Underlying Cardiac Excitation-contraction Coupling
Published on: August 1, 2016
06:48Tuning the Contractility and Deformation Modes of Active Actin-Based Assemblies In Vitro: From Two-Dimensional Active Networks to Liquid Crystal Drops
Published on: July 11, 2025
Related Concept Videos
The Role of Actin and Myosin in Non-muscle Cells
Actin and Myosin in Muscle Contraction
Pathophysiology of Cardiac Performance
Overview of Myosin Structure and Function
Cross-bridge Cycle
The Sarcomere
Each...